Open AccessPotential of a sphingosine 1‑phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
Author(s) -
Yuko Tanaka,
Seiichi Okabe,
Kazuma Ohyashiki,
Akihiko Gotoh
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13231
Subject(s) - s1pr1 , sphingosine , sphingosine kinase , cancer research , cell growth , sphingosine 1 phosphate , sphingosine kinase 1 , sphingosine 1 phosphate receptor , multiple myeloma , angiogenesis , pharmacology , fingolimod , medicine , biology , immunology , receptor , vascular endothelial growth factor a , biochemistry , vascular endothelial growth factor , vegf receptors , multiple sclerosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom